Lyka Labs Ltd. Hits Upper Circuit for the 4th Straight Session on BSE, 16 October 2026

On 16 October 2026, Lyka Labs Ltd. (LYKALABS) hit the upper circuit on BSE at Rs 88.02, a 5% positive move from the previous close of Rs 83.83. The company's market cap stood at Rs 303.07 crore. The upper circuit price for the session was Rs 88.02.

The Lyka Labs upper circuit streak has now run for 4 straight sessions. At the time of writing the stock was locked at its upper circuit level, which makes the session worth noting for short-term market participants.

Key Takeaways

• Lyka Labs Ltd. (LYKALABS) hit the upper circuit on BSE at Rs 88.02 on 16 October 2026.
• The session move was +5% against a previous close of Rs 83.83.
• Market capitalisation stood at Rs 303.07 crore.
• This is the 4th straight session at the upper circuit, with the run starting on 13 October 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Lyka Labs Ltd.
Current Price / LTP	Rs 88.02
Day Move	5%
Previous Close	Rs 83.83
Day Open	Rs 88.02
Day High	Rs 88.02
Day Low	Rs 88.02
Upper Circuit Price	Rs 88.02
Upper Circuit Limit	Rs 88.02
Market Cap	Rs 303.07 crore
Selected Exchange	BSE

All figures above are as of 16 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Lyka Labs Ltd. opened at Rs 88.02 on BSE, compared with a previous close of Rs 83.83. During the session, the stock traded between Rs 88.02 and Rs 88.02 before touching the upper circuit price of Rs 88.02.

The absolute day change was Rs 4.19, while the percentage move was 5%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated upper circuit limit for the session was Rs 88.02, which is the level the price reached.

The Lyka Labs Upper Circuit Streak So Far

This is session 4 of an unbroken run for Lyka Labs Ltd. The streak began on 13 October 2026, from a base price of Rs 72.42. Across the run the stock has moved 21.54% in total.

A repeated upper circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why Lyka Labs Ltd. Hit Upper Circuit

Lyka Labs Ltd. hit the upper circuit after buying interest pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the upper circuit level of Rs 88.02.

What the Lyka Labs Upper Circuit Means

An upper circuit is the maximum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Lyka Labs Ltd., the captured upper circuit price was Rs 88.02 on 16 October 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the upper circuit explains what happened in the session and where the price band was reached.

Lyka Labs Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Lyka Labs Ltd., PB ratio was 3.21, book value was Rs 26.12, EPS was -2.46, ROE was -10.64%, ROCE was -5.96%, dividend yield was 0% and debt-to-assets ratio was 0.53, on a market cap of Rs 303.07 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 3.21, the market valued Lyka Labs Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

A negative ROE means the company reported a loss against shareholder funds in that period, which is worth weighing against a single strong session in either direction.

A PE ratio was not available for Lyka Labs Ltd. That usually happens when reported earnings are negative or have not been refreshed in the dataset, and it means valuation has to be read through other measures rather than assumed cheap or expensive.

For investors tracking upper circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Lyka Labs Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Solara Active Pharma Sciences Ltd.	Rs 3149.79 crore	-	2.48	-0.63%
Advanced Enzyme Technologies Ltd.	Rs 2936.57 crore	17.7	1.77	11.43%
Hikal Ltd.	Rs 2666.38 crore	-	2.24	-3.97%
Fredun Pharmaceuticals Ltd.	Rs 2479.63 crore	56.58	8.13	16.09%
Dishman Carbogen Amcis Ltd.	Rs 2372.13 crore	146.79	0.36	1.56%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Lyka Labs Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Technical Snapshot

The technical snapshot adds context: RSI was 67.13, the 50-day moving average was 81.35 and the 200-day moving average was 69.34.

What Readers Should Know

The main confirmed fact is that Lyka Labs Ltd. hit the upper circuit on BSE at Rs 88.02 on 16 October 2026, with a 5% day move.

The practical limitation after an upper-circuit session is execution. Buyers queue at the band and sellers step back, so the quoted price is not necessarily a price you can transact at. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat upper circuit events as market updates, not standalone investment conclusions. The price band shows strong near-term interest, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did Lyka Labs Ltd. hit upper circuit on 16 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has Lyka Labs Ltd. hit upper circuit in a row?

This is session 4 of the current run, which began on 13 October 2026. This page is updated each session rather than replaced with a new article.

What was LYKALABS share price on 16 October 2026?

The last traded price used in this article was Rs 88.02 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for LYKALABS?

The upper circuit price was Rs 88.02. The stated exchange upper circuit limit was Rs 88.02. The event numbers in this article are aligned to BSE.

What is Lyka Labs Ltd.'s market cap and PE ratio?

Lyka Labs Ltd.'s market cap was Rs 303.07 crore. A PE ratio was not available, which usually points to negative or unrefreshed earnings data.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 16 October 2026.

Does hitting an upper circuit mean Lyka Labs Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Lyka Labs Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Lyka Labs Ltd. the stated limit was Rs 88.02. For this session, Lyka Labs Ltd. moved 5%.